New Strong Buy Stocks for February 9th

Axcelis Technologies (ACLS)

This leading producer of ion implantation equipment used in the fabrication of semiconductors has seen the Zacks Consensus Estimate for its current year earnings increasing 4.1% over the last 60 days.

Axcelis Technologies, Inc. Price and Consensus

Ameriprise Financial (AMP)

This company that provides various financial products and services has seen the Zacks Consensus Estimate for its current year earnings increasing 6.4% over the last 60 days.

Ameriprise Financial, Inc. Price and Consensus

MUST READ:

Legend Who Bought Apple at $1.42 Says Buy TaaS Now

It’s called TaaS – and if you haven’t yet heard of this technological breakthrough, you soon will. [Full Story…]

D.R. Horton (DHI)

This one of the leading national homebuilders has seen the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.

D.R. Horton, Inc. Price and Consensus

New Stock Picks:

Elon Musk Drops HUGE Bombshell About His Empire

Elon Musk, the shrewd billionaire and founder of Tesla, just made a VERY strange confession about the future of his electric car empire.

It’s EXTREMELY shocking. But the secret he reveals could also mint fortunes for smart, fast-moving investors.

This has nothing to do with buying shares of Tesla, either.

His bold prediction could affect nearly 90 million homes and businesses in America in the coming months.

Click here for the stunning details. [Full Story…]

Dover (DOV)

This industrial conglomerate producing a wide range of specialized industrial products and manufacturing equipment has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 4% over the last 60 days.

Dover Corporation Price and Consensus

James Hardie Industries (JHX)

This company that pioneered the development of fibre cement technology in the 1980’s has seen the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.

James Hardie Industries PLC. Price and Consensus

Dylan Jovine

Tiny Biotech Wins $75 Billion Patent

Cambridge firm proves its possible to “Find & Replace” cancer cells. The Wall Street Journal reports this small biotech is “Transforming Medicine.” No wonder Goldman Sachs & Morgan Stanley have been quietly buying shares. [Get the name of this little-known stock here >>>.]